CAMK2N1 has a cancer-suppressive function in colorectal carcinoma via effects on the Wnt/β-catenin pathway

Xiaolong Zhang1, Lifei Tian1, Zeyu Li1

  • 1Department of General Surgery, Shaanxi Provincial People's Hospital, Xi'an, 710068, China.

Insights

Calcium/calmodulin-dependent protein kinase II inhibitor 1 (CAMK2N1) acts as a tumor suppressor in colorectal cancer. Lower CAMK2N1 levels correlate with poor patient survival and promote cancer progression by activating the Wnt/β-catenin pathway.

Area of Science:

  • Oncology
  • Molecular Biology

Background:

  • Deregulation of calcium/calmodulin-dependent protein kinase II inhibitor 1 (CAMK2N1) is implicated in various cancers.
  • Limited research exists on CAMK2N1's role in colorectal carcinoma progression.

Purpose of the Study:

  • To investigate the relationship between CAMK2N1 expression and colorectal carcinoma progression.
  • To elucidate the underlying molecular mechanisms of CAMK2N1's function in colorectal cancer.

Main Methods:

  • Analysis of CAMK2N1 levels in colorectal carcinoma tissues and correlation with patient survival.
  • In vitro studies using colorectal carcinoma cell lines with CAMK2N1 overexpression and silencing.
  • Investigation of CAMK2N1's effect on Wnt/β-catenin pathway components.
  • In vivo tumorigenicity assays in nude mice.

Main Results:

  • CAMK2N1 levels were significantly decreased in colorectal carcinoma tissues, correlating with poorer overall survival.
  • CAMK2N1 overexpression suppressed proliferation, cell cycle progression, metastasis, and chemoresistance.
  • CAMK2N1 silencing led to opposite effects, enhancing cancer phenotypes.
  • CAMK2N1 negatively regulated the Wnt/β-catenin pathway by reducing levels of key signaling molecules.
  • CAMK2N1-mediated tumor inhibition was dependent on Wnt/β-catenin pathway suppression.
  • Tumorigenicity of CAMK2N1-overexpressing cells was significantly reduced in vivo.

Conclusions:

  • CAMK2N1 exhibits a tumor-suppressive function in colorectal carcinoma.
  • CAMK2N1 inhibits colorectal cancer progression primarily through the suppression of the Wnt/β-catenin signaling pathway.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.9K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
2.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K